Cancer/Radiotherapie
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q4 | 23.5% | 0.481 | Q2 | 59.6% |
| 2024 | 1.4 | Q3 | 31.8% | 0.450 | Q3 | 58.7% |
| 2023 | 1.5 | Q3 | 39.5% | 0.405 | Q3 | 58.1% |
| 2022 | 1.3 | Q4 | 25.6% | 0.330 | Q3 | 53.6% |
| 2021 | 1.2 | Q4 | 36.3% | 0.318 | Q3 | 53.1% |
| 2020 | — | — | 0.288 | Q3 | 49.0% | |
| 2019 | — | — | 0.344 | Q3 | 56.7% | |
| 2018 | — | — | 0.294 | Q3 | 49.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF